Loading clinical trials...
Loading clinical trials...
Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in Acute on Chronic Liver Failure (ACLF)
Conditions
Interventions
MEX-CD1 Dialysis
Locations
2
France
Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie
Lyon, Auvergne-Rhône-Alpes, France
CHU Pontchaillou
Rennes, France
Start Date
June 21, 2024
Primary Completion Date
July 1, 2025
Completion Date
October 1, 2025
Last Updated
May 8, 2025
NCT06948565
NCT06837766
NCT06285253
NCT07422948
NCT06987968
NCT07276568
Lead Sponsor
Mexbrain
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions